✦ LIBER ✦

Oral beclomethasone dipropionate versus oral 5-aminosalicylic acid in the treatment of active ulcerative colitis: A randomised, 4 week, controlled study

✍ Scribed by F. Rizzello; P. Gionchetti; D. Valpiani; A. Andriulli; S. Adamo; T. Casetti; E. Colombo; A. D'Arienzo; G. Novelli; G. D'Albasio; M. Campieri

Book ID: 119630370
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 142 KB
Volume: 33
Category: Article
ISSN: 1590-8658
DOI: 10.1016/s1590-8658(01)80277-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of topical versus oral 5-aminos

Efficacy of topical versus oral 5-aminosalicylate for treatment of 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats

✍ Li, Jin; Chen, Cheng; Cao, Xiao-nian; Wang, Gui-hua; Hu, Jun-bo; Wang, Jing 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 Chinese ⚖ 728 KB

Usefulness of oral beclometasone dipropi

Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: The RECLICU Study

✍ Tiago Nunes; Manuel Barreiro-de Acosta; Pilar Nos; Ignacio Marin-Jiménez; Fernan 📂 Article 📅 2010 🏛 Oxford University Press 🌐 English ⚖ 462 KB

Trial of trefoil factor 3 enemas, in com

Trial of trefoil factor 3 enemas, in combination with oral 5-aminosalicylic acid, for the treatment of mild-to-moderate left-sided ulcerative colitis

✍ A. Mahmood; L. Melley; A. J. Fitzgerald; S. Ghosh; R. J. Playford 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Efficacy and safety of a once-yearly i.v

Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study

✍ Eric S Orwoll; Paul D Miller; Jonathan D Adachi; Jacques Brown; Robert A Adler; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 216 KB

## Abstract Zoledronic acid (ZOL) has shown beneficial effects on bone turnover and bone mineral density (BMD) in postmenopausal osteoporosis. This study compared the efficacy and safety of a once‐yearly i.v. infusion of ZOL with weekly oral alendronate (ALN) in men with osteoporosis. In this multi